Literature DB >> 7172497

Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE).

W Cullmann, P M Kövary, N Müller, W Dick.   

Abstract

The intrinsic clotting, the kinin generating and the fibrinolytic systems were investigated in 10 patients with hereditary angioedema (HAE), 10 patients with chronic urticaria and 18 healthy volunteers. In spite of the fact that patients suffering from HAE severely lack C1 INH, neither the intrinsic coagulation nor the fibrinolytic systems are impaired. There was a slight decrease of plasma kallikrein--as already known--and moreover a greater decrease in HMW-kininogen, and increase in Factor XII levels. Furthermore, activation of pre-kallikrein was delayed in these patients. These findings make it apparent that lowered HMW-kininogen levels compensate the lack of C1 INH, thus preventing an enhanced activation of the intrinsic clotting and the fibrinolytic systems.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7172497      PMCID: PMC1536709     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Inactivation and binding of human plasma kallikrein by antithrombin III and heparin.

Authors:  A M Venneröd; K Laake; A K Solberg; S Strömland
Journal:  Thromb Res       Date:  1976-11       Impact factor: 3.944

2.  [Plasminogen determination, using a chromogenic tripeptidic substrate (author's transl)].

Authors:  J Soria; C Soria; M Samama
Journal:  Pathol Biol (Paris)       Date:  1976-12

3.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.

Authors:  H L Meier; J V Pierce; R W Colman; A P Kaplan
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.

Authors:  A D Schreiber; A P Kaplan; K F Austen
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Interaction of plasma kallikrein with the C1 inhibitor.

Authors:  I Gigli; J W Mason; R W Colman; K F Austen
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

7.  Inhibitors of kallikrein in human plasma.

Authors:  D J McConnell
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

8.  Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.

Authors:  A C Teger-Nilsson; P Friberger; E Gyzander
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

9.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

10.  Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.

Authors:  P C Harpel
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

View more
  4 in total

1.  Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.

Authors:  M Cugno; J Nuijens; E Hack; A Eerenberg; D Frangi; A Agostoni; M Cicardi
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  Interaction between C1-INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticaria.

Authors:  K Bork; G Witzke; K Artmann; P Benes; M Böckers; W Kreuz
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

3.  Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.

Authors:  L R Shoemaker; S J Schurman; V H Donaldson; A E Davis
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

Review 4.  Bradykinin: Inflammatory Product of the Coagulation System.

Authors:  Zonne Hofman; Steven de Maat; C Erik Hack; Coen Maas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.